216 related articles for article (PubMed ID: 15715043)
21. Coexistence of corticotroph adenoma and thyrotroph hyperplasia in a dog.
Teshima T; Hara Y; Shigihara K; Takekoshi S; Nezu Y; Harada Y; Yogo T; Teramoto A; Osamura RY; Tagawa M
J Vet Med Sci; 2009 Jan; 71(1):93-8. PubMed ID: 19194082
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical Evaluation of Canine Pituitary Adenomas Obtained by Transsphenoidal Hypophysectomy.
Miller MA; Owen TJ; Bruyette DS; Scott-Moncrieff JC; Ramos-Vara JA; Weng HY; Chen AV; Martin LG; DuSold DM
Vet Pathol; 2018 Nov; 55(6):889-895. PubMed ID: 29925292
[TBL] [Abstract][Full Text] [Related]
23. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic efficacy of plasma ACTH-measurement by a chemiluminometric assay in canine hyperadrenocorticism].
Zeugswetter F; Pagitz M; Hittmair K; Schwendenwein I
Schweiz Arch Tierheilkd; 2011 Mar; 153(3):111-6. PubMed ID: 21360448
[TBL] [Abstract][Full Text] [Related]
25. ACTH precursors characterize the ectopic ACTH syndrome.
Stewart PM; Gibson S; Crosby SR; Penn R; Holder R; Ferry D; Thatcher N; Phillips P; London DR; White A
Clin Endocrinol (Oxf); 1994 Feb; 40(2):199-204. PubMed ID: 8137518
[TBL] [Abstract][Full Text] [Related]
26. Dogs with macroadenomas have lower body temperature and heart rate than dogs with microadenomas.
Benchekroun G; Desquilbet L; Herrtage ME; Jeffery ND; Rosenberg D; Granger N
Vet J; 2017 Sep; 227():42-45. PubMed ID: 29031329
[TBL] [Abstract][Full Text] [Related]
27. TRH-induced secretion of adrenocorticotropin and cortisol in dogs with pituitary-dependent hypercortisolism.
Pijnacker T; Knies M; Galac S; Sanders K; Mol JA; Kooistra HS
Vet Q; 2018 Dec; 38(1):72-78. PubMed ID: 30362899
[TBL] [Abstract][Full Text] [Related]
28. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
Hanson JM; Mol JA; Leegwater PA; Bilodeau S; Drouin J; Meij BP
Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of perioperative profiles of ACTH and cortisol for recurrence after transsphenoidal hypophysectomy in dogs with corticotroph adenomas.
van Rijn SJ; Hanson JM; Zierikzee D; Kooistra HS; Penning LC; Tryfonidou MA; Meij BP
J Vet Intern Med; 2015; 29(3):869-76. PubMed ID: 25959680
[TBL] [Abstract][Full Text] [Related]
30. Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].
Kageyama K; Oki Y; Nigawara T; Suda T; Daimon M
Endocr J; 2014; 61(10):941-8. PubMed ID: 24974880
[TBL] [Abstract][Full Text] [Related]
31. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
Bertagna X
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
[TBL] [Abstract][Full Text] [Related]
32. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
[TBL] [Abstract][Full Text] [Related]
33. Targeting the ERK pathway for the treatment of Cushing's disease.
Zhang D; Bergsneider M; Wang MB; Heaney AP
Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
[TBL] [Abstract][Full Text] [Related]
34. High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors.
Raffin-Sanson ML; Massias JF; Dumont C; Raux-Demay MC; Proeschel MF; Luton JP; Bertagna X
J Clin Endocrinol Metab; 1996 Dec; 81(12):4272-7. PubMed ID: 8954027
[TBL] [Abstract][Full Text] [Related]
35. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
Orth DN; Peterson ME; Drucker WD
Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.
Pereda MP; Lohrer P; Kovalovsky D; Perez Castro C; Goldberg V; Losa M; Chervín A; Berner S; Molina H; Stalla GK; Renner U; Arzt E
Exp Clin Endocrinol Diabetes; 2000; 108(3):202-7. PubMed ID: 10926317
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of transsphenoidal surgery on endocrinological status and serum chemistry parameters in dogs with Cushing's disease.
Hara Y; Teshima T; Taoda T; Ishino H; Nezu Y; Harada Y; Yogo T; Masuda H; Teramoto A; Tagawa M
J Vet Med Sci; 2010 Apr; 72(4):397-404. PubMed ID: 19996557
[TBL] [Abstract][Full Text] [Related]
38. Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.
Castillo V; Theodoropoulou M; Stalla J; Gallelli MF; Cabrera-Blatter MF; Haedo MR; Labeur M; Schmid HA; Stalla GK; Arzt E
Neuroendocrinology; 2011; 94(2):124-36. PubMed ID: 21525729
[TBL] [Abstract][Full Text] [Related]
39. [Pathology and pathogenesis of pituitary corticotroph adenoma].
Trouillas J
Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M
Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
